Quest launches blood test for Alzheimer’s disease aimed at general consumers
Quest Diagnostics has released the AD-Detect test for general consumers to gauge beta amyloid levels, which are associated with neurodegenerative conditions. The test is for anyone “who has a family history of Alzheimer’s disease, is experiencing memory loss, or is experiencing early cognitive decline,” according to Quest.